Society for Clinical Research Sites Welcomes the Nomination of Dr. Robert Califf as FDA Commissioner

ELLICOTT CITY, Md., Oct. 5, 2015 /PRNewswire/ -- Christine Pierre, President of the Society for Clinical Research Sites (SCRS), today issued the following statement on President Barack Obama's Sept. 15 nomination of Dr. Robert Califf to serve as the next Commissioner of the Food and Drug Administration:

"SCRS welcomes the nomination of Dr. Califf as FDA Commissioner.  Rob has worked closely with SCRS on many initiatives including being a member of SCRS' Leadership Council and also on many projects through the Clinical Trials Transformation Initiative.  His extensive experience and commitment to the ethical and efficient process needed to conduct research will be an invaluable foundation for him to bring to this new role.  Rob's vast experience and unwavering commitment to bringing safe and effective new treatments to patients will greatly benefit the agency and the general public." 

About SCRS
SCRS is a global trade organization founded in 2012 which represents over 2,600 research sites in 42 countries. SCRS' mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites, as well as companies that sponsor or support the work conducted at clinical research sites, will benefit from membership and partnership. Visit MySCRS.org.

SOURCE Society for Clinical Research Sites

Related Links

http://myscrs.org